Drug firm Glenmark Pharmaceuticals Ltd said its consolidated net profit rose 38% to Rs111.6 crore for the second quarter ended 30 September 2010 from Rs80.9 crore in the same period last financial year.
During the quarter to end-September, its total revenues rose to Rs741.4 crore from Rs602.5 crore same period last fiscal.
On Thursday, Glenmark Pharma shares ended 3.3% up at Rs324 on the Bombay Stock Exchange, while the benchmark Sensex closed 1.1% down at 20,005 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
